Endo Gross Profit 2006-2019 | ENDP

Endo gross profit from 2006 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Endo Annual Gross Profit
(Millions of US $)
2018 $1,315
2017 $1,240
2016 $1,375
2015 $1,193
2014 $1,149
2013 $1,238
2012 $1,680
2011 $1,577
2010 $1,211
2009 $1,086
2008 $993
2007 $868
2006 $701
2005 $628
Endo Quarterly Gross Profit
(Millions of US $)
Q3 2019 $340
Q2 2019 $312
Q1 2019 $329
Q4 2018 $353
Q3 2018 $333
Q2 2018 $333
Q1 2018 $297
Q4 2017 $263
Q3 2017 $272
Q2 2017 $336
Q1 2017 $369
Q4 2016 $485
Q3 2016 $327
Q2 2016 $289
Q1 2016 $275
Q4 2015 $264
Q3 2015 $303
Q2 2015 $296
Q1 2015 $330
Q4 2014 $289
Q3 2014 $313
Q2 2014 $289
Q1 2014 $258
Q4 2013 $-8
Q3 2013 $403
Q2 2013 $439
Q1 2013 $404
Q4 2012 $407
Q3 2012 $456
Q2 2012 $491
Q1 2012 $326
Q4 2011 $421
Q3 2011 $457
Q2 2011 $371
Q1 2011 $328
Q4 2010 $342
Q3 2010 $310
Q2 2010 $289
Q1 2010 $270
Q4 2009 $292
Q3 2009 $264
Q2 2009 $278
Q1 2009 $252
Q4 2008 $271
Q3 2008 $246
Q2 2008 $243
Q1 2008 $234
Q4 2007 $243
Q3 2007 $218
Q2 2007 $202
Q1 2007 $205
Q4 2006 $194
Q3 2006 $173
Q2 2006 $178
Q1 2006 $156
Q4 2005 $182
Q3 2005 $184
Q2 2005 $154
Q1 2005 $108
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.277B $2.914B
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $63.617B 36.80
Takeda Pharmaceutical (TAK) Japan $54.955B 9.74
Astellas Pharma (ALPMY) Japan $29.466B 14.72
Eisai (ESALY) Japan $21.073B 40.62
UCB SA (UCBJF) Belgium $18.905B 0.00
Grifols, S.A (GRFS) Spain $16.144B 21.15
Merck (MKGAF) Germany $15.852B 21.63
Ono Pharmaceutical (OPHLF) Japan $11.311B 24.18
Neurocrine Biosciences (NBIX) United States $8.486B 235.77
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Catalent (CTLT) United States $7.680B 31.60
Ionis Pharmaceuticals (IONS) United States $7.496B 22.49
Jazz Pharmaceuticals (JAZZ) Ireland $6.349B 7.74
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
IPSEN SA ADR (IPSEY) France $5.641B 0.00
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $4.584B 13.94
United Therapeutics (UTHR) United States $4.423B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.660B 67.93
Evotec AG (EVTCY) Germany $3.643B 58.78
Nektar Therapeutics (NKTR) United States $3.612B 0.00
FibroGen (FGEN) United States $3.539B 104.00
PTC Therapeutics (PTCT) United States $3.300B 0.00
Sage Therapeutics (SAGE) United States $2.695B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.675B 10.82
ChemoCentryx (CCXI) United States $2.565B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.955B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.883B 22.89
Xencor (XNCR) United States $1.833B 74.86
Pacira Pharmaceuticals (PCRX) United States $1.800B 49.22
Heron Therapeutics (HRTX) United States $1.615B 0.00
Corcept Therapeutics (CORT) United States $1.529B 17.10
Tilray (TLRY) Canada $1.461B 0.00
Esperion Therapeutics (ESPR) United States $1.429B 0.00
USANA Health Sciences (USNA) United States $1.402B 14.72
CLINIGEN GP (CLIGF) United Kingdom $1.392B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.358B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.134B 15.79
Zogenix (ZGNX) United States $1.048B 0.00
Karyopharm Therapeutics (KPTI) United States $1.008B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.993B 30.75
Akebia Therapeutics (AKBA) United States $0.987B 0.00
Radius Health (RDUS) United States $0.911B 0.00
Portola Pharmaceuticals (PTLA) United States $0.791B 0.00
Aerie Pharmaceuticals (AERI) United States $0.790B 0.00
Collegium Pharmaceutical (COLL) United States $0.727B 0.00
ImmunoGen (IMGN) United States $0.657B 0.00
Flexion Therapeutics (FLXN) United States $0.592B 0.00
Molecular Templates (MTEM) United States $0.579B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.511B 0.00
TherapeuticsMD (TXMD) United States $0.451B 0.00
Ardelyx (ARDX) United States $0.440B 0.00
Translate Bio (TBIO) United States $0.435B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.431B 52.25
BioSpecifics Technologies Corp (BSTC) United States $0.426B 18.35
Innate Pharma SA (IPHYF) France $0.423B 0.00
Indivior (INVVY) United States $0.417B 2.48
BioCryst Pharmaceuticals (BCRX) United States $0.407B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.382B 0.00
Siga Technologies (SIGA) United States $0.375B 8.57
Organogenesis Holdings (ORGO) United States $0.370B 0.00
Calithera Biosciences (CALA) United States $0.357B 0.00
Lannett Co Inc (LCI) United States $0.353B 5.69
Harpoon Therapeutics (HARP) United States $0.350B 0.00
DURECT (DRRX) United States $0.342B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 0.00
Recro Pharma (REPH) United States $0.337B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.326B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.314B 0.00
Rafael Holdings (RFL) United States $0.311B 0.00
Concert Pharmaceuticals (CNCE) United States $0.301B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.271B 0.00
OptiNose (OPTN) United States $0.268B 0.00
KalVista Pharmaceuticals (KALV) United States $0.239B 0.00
Ocular Therapeutix (OCUL) United States $0.221B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.217B 0.00
MEI Pharma (MEIP) United States $0.212B 0.00
Taiwan Liposome (TLC) Taiwan $0.185B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.183B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.178B 30.73
Matinas Biopharma Holdings (MTNB) United States $0.169B 0.00
Jounce Therapeutics (JNCE) United States $0.151B 2.79
IMV INC (IMV) Canada $0.122B 0.00
VAXART, INC (VXRT) United States $0.118B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.110B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.103B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.098B 0.00
Xeris Pharmaceuticals (XERS) United States $0.097B 0.00
CannTrust Holdings (CTST) Canada $0.095B 0.00
Otonomy (OTIC) United States $0.093B 0.00
Aquestive Therapeutics (AQST) United States $0.089B 0.00
Redhill Biopharma (RDHL) Israel $0.089B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.085B 0.00
Generex Biotechnology (GNBT) United States $0.082B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Champions Oncology (CSBR) United States $0.075B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.069B 0.00
Onconova Therapeutics (ONTX) United States $0.065B 0.00
MediWound (MDWD) Israel $0.065B 0.00
CV Sciences (CVSI) United States $0.065B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 18.64
RENEURON GP (RNUGF) United Kingdom $0.061B 0.00
Nivalis Therapeutics (ALPN) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
IsoRay (ISR) United States $0.052B 0.00
Natural Alternatives (NAII) United States $0.051B 23.13
AgeX Therapeutics (AGE) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
Aclaris Therapeutics (ACRS) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.045B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
PolarityTE (PTE) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
China SXT Pharmaceuticals (SXTC) China $0.028B 0.00
Biomerica (BMRA) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
ElectroCore (ECOR) United States $0.023B 0.00
Vical (BBI) United States $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
India Globalization Capital (IGC) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Cardiome Pharma (CORV) Canada $0.017B 0.00
Shineco (TYHT) China $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 0.00
Hemispherx BioPharma (AIM) United States $0.014B 0.00
Lipocine (LPCN) United States $0.013B 0.00
Heat Biologics (HTBX) United States $0.012B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.012B 0.00
Novan (NOVN) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00